Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Tomomi Katanoda"'
Autor:
Kazutaka Oda, Tomomi Katanoda, Hitomi Arakaki, Taiki Katsume, Kaho Matsuyama, Hirofumi Jono, Hideyuki Saito
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 10, Iss 1, Pp 1-4 (2024)
Abstract Background Treating refractory status epilepticus (RSE) remains a challenge. Thiamylal can be used as a second- or third-line treatment; however, its potential to induce cytochrome P450 (CYP) activity may reduce the concentration of antiepil
Externí odkaz:
https://doaj.org/article/5a3d2d3c279d47d391ed5bd52b1d0345
Autor:
Kazutaka Oda, Shota Uchino, Kayo Kurogi, Mai Horikawa, Naoya Matsumoto, Kou Yonemaru, Hitomi Arakaki, Taiki Katsume, Kaho Matsuyama, Tomomi Katanoda, Yuki Narita, Koji Iwamura, Hirofumi Jono, Hideyuki Saito
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 7, Iss 1, Pp 1-5 (2021)
Abstract Background Therapeutic drug monitoring for voriconazole is recommended for its optimum pharmacotherapy. Although the feedback of the measurement result of serum voriconazole concentration by outsourcing needs a certain time (days within a 1
Externí odkaz:
https://doaj.org/article/fb06b5ff47134bc7a64a5605f08bee11
Autor:
Kazutaka Oda, Yumi Hashiguchi, Tomomi Katanoda, Hirotomo Nakata, Hirofumi Jono, Hideyuki Saito
Publikováno v:
Microbiology Spectrum, Vol 9, Iss 1 (2021)
ABSTRACT The combined use of vancomycin (VCM) and tazobactam/piperacillin (TAZ/PIPC) is a major risk factor for nephrotoxicity. We sought to evaluate interventions against the combined use of VCM and TAZ/PIPC. This retrospective cohort study involved
Externí odkaz:
https://doaj.org/article/09d4c2b177504e609ca404616cf15d11
Autor:
Kazutaka Oda, Hidenobu Kamohara, Tomomi Katanoda, Yumi Hashiguchi, Koji Iwamura, Kisato Nosaka, Hirofumi Jono, Hideyuki Saito
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 5, Iss 1, Pp 1-4 (2019)
Abstract Background Despite the high mortality of patients with sepsis and carbapenem-resistant bacteria infection, appropriate antimicrobial therapies are yet to be established. Here, we have reported the case of a patient with pneumonia that subseq
Externí odkaz:
https://doaj.org/article/c2cca406f6984e14a1ea7a0db4db1a55
Autor:
Koji Iwamura, Mai Horikawa, Kaho Matsuyama, Tomomi Katanoda, Hideyuki Saito, Kayo Kurogi, Yuki Narita, Kazutaka Oda, Shota Uchino, Taiki Katsume, Kou Yonemaru, Hirofumi Jono, Naoya Matsumoto, Hitomi Arakaki
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 7, Iss 1, Pp 1-5 (2021)
Journal of Pharmaceutical Health Care and Sciences
Journal of Pharmaceutical Health Care and Sciences
Background Therapeutic drug monitoring for voriconazole is recommended for its optimum pharmacotherapy. Although the feedback of the measurement result of serum voriconazole concentration by outsourcing needs a certain time (days within a 1 week), th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::606dabf6de1b5a8167a43f3c45ce778e
https://doaj.org/article/fb06b5ff47134bc7a64a5605f08bee11
https://doaj.org/article/fb06b5ff47134bc7a64a5605f08bee11
Autor:
Hirofumi Jono, Toshikazu Miyakawa, Yumi Hashiguchi, Ayami Yamaguchi, Koji Iwamura, Hideyuki Saito, Kazutaka Oda, Kisato Nosaka, Tomomi Katanoda
Publikováno v:
Journal of Infection and Chemotherapy. 26:498-501
Cefepime is known to exert bactericidal activity against Pseudomonas aeruginosa. Cefepime-induced neurotoxicity, most likely caused by increased exposure, has recently become a major concern in clinical practice; therefore, appropriate dose reduction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdfb9699177b533008a81abbb7556f29
https://doi.org/10.1016/j.jiac.2019.10.006
https://doi.org/10.1016/j.jiac.2019.10.006
Autor:
Hideyuki Saito, Tomomi Katanoda, Kisato Nosaka, Koji Iwamura, Yuki Narita, Shoji Kondo, Kazutaka Oda, Hirofumi Jono, Yumi Hashiguchi
Publikováno v:
Journal of Infection and Chemotherapy. 26:444-450
Although the superiority of vancomycin dosing based on area under the concentration-time curve (AUC0-24) over that based on trough concentration has been reported, a dosing strategy to achieve the target AUC0-24 has yet to be developed. The objective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebb6c16489e4a21ecae1095062452199
https://doi.org/10.1016/j.jiac.2019.11.009
https://doi.org/10.1016/j.jiac.2019.11.009
Autor:
Hirofumi Jono, Yumi Hashiguchi, Kazutaka Oda, Hirotomo Nakata, Hideyuki Saito, Tomomi Katanoda
Publikováno v:
Microbiology Spectrum, Vol 9, Iss 1 (2021)
Microbiology Spectrum
Microbiology Spectrum
The combined use of vancomycin (VCM) and tazobactam/piperacillin (TAZ/PIPC) is a major risk factor for nephrotoxicity. We sought to evaluate interventions against the combined use of VCM and TAZ/PIPC. This retrospective cohort study involved patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5291046f4671c96ec515d0559f2375fd
https://journals.asm.org/doi/10.1128/Spectrum.00355-21
https://journals.asm.org/doi/10.1128/Spectrum.00355-21
Publikováno v:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 26(11)
Bacteremia is often caused by gram-negative bacteria (represented by EKP; Escherichia coli, Klebsiella species, and Proteus mirabilis), and the excessive use of cefazolin, as the first-line antimicrobial in its treatment, has been a source of concern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c7ddc968d8fc6bcc39110966db185f8
https://pubmed.ncbi.nlm.nih.gov/32828676
https://pubmed.ncbi.nlm.nih.gov/32828676
Autor:
Hirofumi Jono, Koji Iwamura, Kisato Nosaka, Kazutaka Oda, Tomomi Katanoda, Hideyuki Saito, Hidenobu Kamohara, Yumi Hashiguchi
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences
Journal of Pharmaceutical Health Care and Sciences, Vol 5, Iss 1, Pp 1-4 (2019)
Journal of Pharmaceutical Health Care and Sciences, Vol 5, Iss 1, Pp 1-4 (2019)
Background Despite the high mortality of patients with sepsis and carbapenem-resistant bacteria infection, appropriate antimicrobial therapies are yet to be established. Here, we have reported the case of a patient with pneumonia that subsequently de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a7aa11ead4ef03177559ef5e4285315
http://europepmc.org/articles/PMC6613258
http://europepmc.org/articles/PMC6613258